The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
Abstract
BACKGROUND: Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a debilitating multisystem condition affecting more than 1 million adults in the United States. PURPOSE: To determine benefits and harms of treatments for adults with ME/CFS and identify future research needs. DATA SOURCES: MEDLINE, PsycINFO, and Cochrane databases (January 1988 to September 2014); clinical trial registries; reference lists; and manufacturer information. STUDY SELECTION: English-language randomized trials of the effectiveness and adverse effects of ME/CFS treatments. DATA EXTRACTION: Data on participants, study design, analysis, follow-up, and results were extracted and confirmed. Study quality was dual-rated by using prespecified criteria; discrepancies were resolved through consensus. DATA SYNTHESIS: Among 35 treatment trials enrolling participants primarily meeting the 1994 Centers for Disease Control and Prevention and Oxford case definitions of CFS, the immune modulator rintatolimod improved some measures of exercise performance compared with placebo in 2 trials (low strength of evidence). Trials of galantamine, hydrocortisone, IgG, valganciclovir, isoprinosine, fluoxetine, and various complementary medicines were inconclusive (insufficient evidence). Counseling therapies and graded exercise therapy compared with no treatment, relaxation, or support improved fatigue, function, global improvement, and work impairment in some trials; counseling therapies also improved quality of life (low to moderate strength of evidence). Harms were rarely reported across studies (insufficient evidence). LIMITATION: Trials were heterogeneous and were limited by size, number, duration, applicability, and methodological quality. CONCLUSION: Trials of rintatolimod, counseling therapies, and graded exercise therapy suggest benefit for some patients meeting case definitions for CFS, whereas evidence for other treatments and harms is insufficient. More definitive studies comparing participants meeting different case definitions, including ME, and providing subgroup analysis are needed to fill research gaps.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systematic reviews have shown low strength of evidence for the effectiveness of different complementary therapies [19], cognitive-behavioral therapy (CBT), counseling and behavioral therapies [14,22], and graded exercise therapy [23] for improvement of fatigue, physical functioning, sleep, and quality of life in patients with ME/CFS.”
From Systematic review of mind‐body interventions to treat myalgic encephalomyelitis/chronic fatigue syndrome (2021) · cites this paper as [19]
In the citing paper
“There is no cure for ME/CFS nor any FDA or Health Canada approved medication to treat it [14,19], therefore the focus tends to be on managing and minimizing the symptoms and improving quality of life.”
From Systematic review of mind‐body interventions to treat myalgic encephalomyelitis/chronic fatigue syndrome (2021) · cites this paper as [19]
In the citing paper
“It has long been suspected that the Oxford criteria may therefore fail to exclude individuals with other fatiguing conditions [14,19].”
From Systematic review of mind‐body interventions to treat myalgic encephalomyelitis/chronic fatigue syndrome (2021) · cites this paper as [19]
In the citing paper
“Although some studies indicate an effect by counseling and CBT, results remain inconsistent [19] spurring interest in third-wave cognitive therapies like ACT [20].”
Citations
Cites
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969
Chronic Fatigue Syndrome: A Working Case Definition
Holmes, G. P., KAPLAN, J. E., GANTZ, N. M., KOMAROFF, A. L., SCHONBERGER, L. B., STRAUS, S. E., Jones, J. F., DUBOIS, R. E., CUNNINGHAM-RUNDLES, C., Pahwa, S. G., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-387 · Cited by 1,713
Myalgic encephalomyelitis: International Consensus Criteria
Carruthers, B. M., van de Sande, M. I., Meirleir, K. L. D., Klimas, N. G., Broderick, G., Mitchell, T., Staines, D., Powles, A. C. P., Speight, N., Vallings, R., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02428.x · Cited by 1,234 · cited 1×
“There is uncertainty regarding the cause of ME/ CFS, whether it is a pathologically discrete syndrome (2, 4), whether ME should be considered a subset of CFS or its own distinct disease (6), and whether symptoms are nonspecific and shared by other disease entities.”
BackgroundCarruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., Powles, A. C. P., et al. (2003) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v11n01_02 · Cited by 1,180
A report—Chronic fatigue syndrome: Guidelines for research
Sharpe, M. C. (1991) · Journal of the Royal Society of Medicine · doi:10.1177/014107689108400224 · Cited by 1,026 · cited 1×
“Trials enrolled predominantly middle-aged women from ME/ CFS specialty clinics; used CFS case definitions, primarily the 1994 CDC (3) or Oxford criteria (56), to determine participant eligibility; had small sample sizes (27 trials had <100 participants); and were conducted in the United States and Western Europe (16).”
MethodWhite, P., Goldsmith, K., Johnson, A., Potts, L., Walwyn, R., DeCesare, J., Baber, H., Burgess, M., Clark, L., Cox, D., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60096-2 · Cited by 897
Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial.
Sharpe, M., Hawton, K., Simkin, S., Surawy, C., Hackmann, A., Klimes, I., Peto, T., Warrell, D., & Seagroatt, V. (1996) · BMJ · doi:10.1136/bmj.312.7022.22 · Cited by 528 · cited 1×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundA LIKELIHOOD APPROACH TO META-ANALYSIS WITH RANDOM EFFECTS
Hardy, R., & Thompson, S. G. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960330)15:6 · Cited by 522
Interventions for the Treatment and Management of Chronic Fatigue Syndrome: A Systematic Review
Whiting, P., Bagnall, A.-M., Sowden, A. J., Cornell, J. E., Mulrow, C. D., & Ramírez, G. (2001) · JAMA · doi:10.1001/jama.286.11.1360 · Cited by 509
Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.3.408 · Cited by 491 · cited 1×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundExercise therapy for chronic fatigue syndrome
Larun, L., Brurberg, K. G., Odgaard‐Jensen, J., & Price, J. R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003200.pub7 · Cited by 485
Prevalence and Incidence of Chronic Fatigue Syndrome in Wichita, Kansas
Reyes, M., Nisenbaum, R. A., Hoaglin, D. C., Unger, E. R., Emmons, C., Randall, B., Stewart, J. A., Abbey, S. E., Jones, J. F., Gantz, N. M., et al. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1530 · Cited by 439 · cited 1×
“3% prevalence of ME/CFS in the United States in 1997, corresponding to more than 1 million adults (12).”
BackgroundRandomised controlled trial of graded exercise in patients with the chronic fatigue syndrome
Fulcher, K. Y., & White, P. D. (1997) · BMJ · doi:10.1136/bmj.314.7095.1647 · Cited by 431
Wearden, A. J., Morriss, R. K., Mullis, R., Strickland, P., Pearson, D. J., Appleby, L., Campbell, I. T., & Morris, J. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.6.485 · Cited by 249 · cited 5×
“These included GET involving an exercise plan with structured incremental increases in exercise over time (23, 48, 50, 52, 53), qigong exercise (49, 51), and home orthostatic training (54).”
BackgroundMethodInfluentialMoss-Morris, R. E., Sharon, C., Tobin, R., & Baldi, J. C. (2005) · Journal of Health Psychology · doi:10.1177/1359105305049774 · Cited by 242 · cited 21×
“846 Annals of Internal Medicine • Vol. 162 No. 12 • 16 June 2015 www.annals.org Downloaded From: http://annals.org/ on 07/21/2018 seling and behavior therapies were associated with fewer harms (low strength of evidence) than medications and GET (insufficient evidence).”
BackgroundMethodInfluentialAcyclovir Treatment of the Chronic Fatigue Syndrome
Straus, S. E., Dale, J. K., Tobi, M., Lawley, T. J., Preble, O. T., Blaese, R. M., Hallahan, C. W., & Henle, W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192602 · Cited by 235
Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia
Reeves, W. C., Jones, J. F., Maloney, E. M., Heim, C. C., Hoaglin, D. C., Boneva, R. S., Morrissey, M., & Devlin, R. G. (2007) · Population Health Metrics · doi:10.1186/1478-7954-5-5 · Cited by 222
Low-Dose Hydrocortisone for Treatment of Chronic Fatigue Syndrome
McKenzie, R., O’Fallon, A., Dale, J. K., Demitrack, M. A., Sharma, G., Knoll, M. D., Garcı́a-Borreguero, D., Blackwelder, W. C., & Straus, S. E. (1998) · JAMA · doi:10.1001/jama.280.12.1061 · Cited by 204
Chambers, D., Bagnall, A., Hempel, S., & Forbes, C. A. (2006) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.99.10.506 · Cited by 198
Fluge, Ø., Bruland, O., Risa, K., Storstein, A. M., Kristoffersen, E. K., Sapkota, D., Næss, H., Dahl, O., Nyland, H., & Mella, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026358 · Cited by 191 · cited 1×
“Additional trials enrolling fewer than 30 participants and with durations less than 12 weeks indicated no statistically significant differences compared with placebo for acyclovir (57) and showed improved 36-item ShortForm Survey (SF-36) scores for physical health and function with rituximab (58).”
BackgroundDeale, A. C., Husain, K., Chalder, T., & Wessely, S. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2038 · Cited by 171 · cited 4×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundInfluentialA controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome
Peterson, P. K., Shepard, J. H., Macres, M., Schenck, C. H., Crosson, J. T., Rechtman, D. J., & Lurie, N. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90172-a · Cited by 159 · cited 6×
“Nine placebo-controlled trials of medications evaluated the effectiveness of rintatolimod (21, 27), valganciclovir (28), galantamine (26), hydrocortisone (22), hydrocortisone plus fludrocortisone (24), IgG (20), isoprinosine (25), and fluoxetine (23).”
BackgroundInfluentialStrayer, D. R., Carter, W. A., Brodsky, I., Cheney, P. R., Peterson, D. L., Salvato, P., Thompson, C., Loveless, M. O., Shapiro, D. E., Elsasser, W., et al. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_1.s88 · Cited by 128 · cited 2×
“One of these 2 trials also reported improvement in measures of function (activities of daily living and Karnofsky Performance Scale score) (21), and the other indicated a reduction in use of other medications to relieve CFS symptoms (27).”
BackgroundA neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome
Morris, G., & Maes, M. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9324-8 · Cited by 117 · cited 1×
“Some propose that an inciting event initiates an immune response that leads to immune and neuroendocrine dysregulation (10, 11).”
BackgroundWearden, A. J., Dowrick, C., Chew-Graham, C., Bentall, R. P., Morriss, R. K., Peters, S., Riste, L., Richardson, G., Lovell, K., Dunn, G., et al. (2010) · BMJ · doi:10.1136/bmj.c1777 · Cited by 116 · cited 4×
“These therapies were compared with usual care, wait-list control, no treatment, relaxation techniques, adaptive pacing (avoiding activities demanding >70% of a participant's perceived energy), anaerobic therapy that promoted gradual return of pleasurable activities (40, 47, 63, 64), graded exercise therapy (GET) (48),…”
BackgroundInfluentialNon-pharmacologic Interventions for CFS: A Randomized Trial
Jason, L. A., Torres-Harding, S., Friedberg, F., Corradi, K., Njoku, M. G., Donalek, J., Reynolds, N., Brown, M., Weitner, B. B., Rademaker, A., et al. (2007) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-007-9090-7 · Cited by 107 · cited 8×
“These therapies were compared with usual care, wait-list control, no treatment, relaxation techniques, adaptive pacing (avoiding activities demanding >70% of a participant's perceived energy), anaerobic therapy that promoted gradual return of pleasurable activities (40, 47, 63, 64), graded exercise therapy (GET) (48),…”
BackgroundInfluentialHo, R. T. H., Chan, J. S. M., Wang, C.-W., Lau, B. W. M., So, K. F., Yuen, L. P., Sham, J. S. T., & Chan, C. L. W. (2012) · Annals of Behavioral Medicine · doi:10.1007/s12160-012-9381-6 · Cited by 103 · cited 3×
“These included GET involving an exercise plan with structured incremental increases in exercise over time (23, 48, 50, 52, 53), qigong exercise (49, 51), and home orthostatic training (54).”
BackgroundMethodGuided self-instructions for people with chronic fatigue syndrome: randomised controlled trial
Knoop, H., van der Meer, J. W. M., & Bleijenberg, G. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051292 · Cited by 98
Alræk, T., Lee, M. S., Choi, T., Cao, H., & Liu, J. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-87 · Cited by 96
O’Dowd, H., Gladwell, P. W., Rogers, C. A., Hollinghurst, S. P., & Gregory, A. C. (2006) · Health Technology Assessment · doi:10.3310/hta10370 · Cited by 94 · cited 3×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundStrayer, D. R., Carter, W. A., Stouch, B. C., Stevens, S. R., Bateman, L., Cimoch, P. J., Lapp, C. W., Peterson, D. L., the Chronic Fatigue Syndrome AMP-516 Study Group, & Mitchell, W. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031334 · Cited by 84 · cited 4×
“Participants taking rintatolimod reported flu-like symptoms, chills, vasodilatation, and dyspnea (27).”
BackgroundInfluentialJason, L. A., Benton, M., Torres‐Harding, S., & Muldowney, K. (2009) · Patient Education and Counseling · doi:10.1016/j.pec.2009.02.015 · Cited by 83
Montoya, J. G., Kogelnik, A. M., Bhangoo, M. S., Lunn, M. R., Flamand, L., Merrihew, L. E., Watt, T., Kubo, J. T., Kim, J. P., & Desai, M. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23713 · Cited by 81 · cited 2×
“In a small, underpowered trial of valganciclovir that enrolled 30 participants with elevated antibody titers who were suspected of having viral-onset ME/CFS, fatigue was improved in the treatment group compared with the placebo group on the basis of 1 scale, but no statistically significant differences were seen for o…”
BackgroundHaney, E. M., Smith, M. E. B., McDonagh, M. S., Pappas, M., Daeges, M., Wasson, N., & Nelson, H. D. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0443 · Cited by 79 · cited 2×
“The Oxford CFS case definition is the least restrictive, and its use as entry criteria could have resulted in selection of participants with other fatiguing illnesses or illnesses that resolve spontaneously with time (16, 71).”
BackgroundNúñez, M., Fernández‐Solà, J., Núñez, E., Fernández-Huerta, J. M., Godás, T., & Gómez‐Gil, E. (2011) · Clinical Rheumatology · doi:10.1007/s10067-010-1677-y · Cited by 78 · cited 3×
“These included GET involving an exercise plan with structured incremental increases in exercise over time (23, 48, 50, 52, 53), qigong exercise (49, 51), and home orthostatic training (54).”
BackgroundMethodLopez, C., Antoni, M., Penedo, F., Weiss, D., Cruess, S., Segotas, M.-C., Helder, L., Siegel, S., Klimas, N., & Fletcher, M. A. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.11.010 · Cited by 71 · cited 3×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundWeatherley-Jones, E., Nicholl, J. P., Thomas, K. J., Parry, G. J., McKendrick, M. W., Green, S. T., Stanley, P., & Spj, L. (2004) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00377-5 · Cited by 70 · cited 3×
“One trial met criteria for good quality (31, 33), 5 for fair quality (29, 32, 34, 35), and 1 for poor quality (30).”
BackgroundVermeulen, R. C., & Scholte, H. R. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000116249.60477.e9 · Cited by 70 · cited 4×
“Harms Patients taking formulations of L-carnitine reported sleeplessness and feeling overstimulated (32).”
BackgroundInfluentialExercise therapy for chronic fatigue syndrome
Larun, L., Brurberg, K. G., Odgaard-Jensen, J., & Price, J. R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003200.pub3 · Cited by 69
Blockmans, D., Persoons, P., Houdenhove, B. V., Lejeune, M., & Bobbaers, H. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00182-7 · Cited by 67
Role of Infection and Neurologic Dysfunction in Chronic Fatigue Syndrome
Komaroff, A. L., & Cho, T. A. (2011) · Seminars in Neurology · doi:10.1055/s-0031-1287654 · Cited by 64 · cited 2×
“However, no specific virus or other infectious agent has been identified, and not all patients experience a preceding febrile illness (10).”
BackgroundJason, L. A., Brown, A. A., Clyne, E., Bartgis, L., Evans, M. A., & Brown, M. M. (2011) · Evaluation & the Health Professions · doi:10.1177/0163278711424281 · Cited by 62
Taylor, R. R. (2004) · American Journal of Occupational Therapy · doi:10.5014/ajot.58.1.35 · Cited by 60 · cited 4×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundInfluentialChan, J. S. M., Ho, R., Wang, C., Yuen, L. P., Sham, J. S. T., & Chan, C. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/485341 · Cited by 57 · cited 2×
“These included GET involving an exercise plan with structured incremental increases in exercise over time (23, 48, 50, 52, 53), qigong exercise (49, 51), and home orthostatic training (54).”
BackgroundMethodEffectiveness of stepped care for chronic fatigue syndrome: A randomized noninferiority trial.
Tummers, M., Knoop, H., & Bleijenberg, G. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0020052 · Cited by 57 · cited 2×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundMediators of the effects on fatigue of pragmatic rehabilitation for chronic fatigue syndrome.
Wearden, A. J., & Emsley, R. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0033561 · Cited by 54 · cited 2×
“These therapies were compared with usual care, wait-list control, no treatment, relaxation techniques, adaptive pacing (avoiding activities demanding >70% of a participant's perceived energy), anaerobic therapy that promoted gradual return of pleasurable activities (40, 47, 63, 64), graded exercise therapy (GET) (48),…”
BackgroundContrasting chronic fatigue syndrome versus myalgic encephalomyelitis/chronic fatigue syndrome
Jason, L. A., Brown, A. A., Evans, M. A., Sunnquist, M., & Newton, J. L. (2013) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2013.774556 · Cited by 54 · cited 1×
“There is uncertainty regarding the cause of ME/ CFS, whether it is a pathologically discrete syndrome (2, 4), whether ME should be considered a subset of CFS or its own distinct disease (6), and whether symptoms are nonspecific and shared by other disease entities.”
BackgroundWalach, H., Bösch, H., Lewith, G. T., Naumann, J., Schwarzer, B., Falk, S., Kohls, N., Haraldsson, E., Wiesendanger, H., Nordmann, A. J., et al. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000116609 · Cited by 53 · cited 3×
“One trial met criteria for good quality (31, 33), 5 for fair quality (29, 32, 34, 35), and 1 for poor quality (30).”
BackgroundTummers, M., Knoop, H., van Dam, A., & Bleijenberg, G. (2012) · Psychological Medicine · doi:10.1017/s0033291712000232 · Cited by 53 · cited 3×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundBurgess, M., Andiappan, M., & Chalder, T. (2011) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465811000543 · Cited by 48 · cited 2×
“The trials were too heterogeneous to allow us to determine whether one type of counseling intervention was more effective than another, and a small trial comparing faceto-face versus telephone CBT indicated no differences between these therapeutic approaches (37).”
BackgroundDougall, D., Johnson, A. L., Goldsmith, K., Sharpe, M., Angus, B., Chalder, T., & White, P. D. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.04.002 · Cited by 46 · cited 1×
“001), but there were no statistically significant differences in serious deterioration measured by a composite score (48, 65).”
BackgroundBazelmans, E., Prins, J. B., Lulofs, R., van der Meer, J. W. M., & Bleijenberg, G. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000085145 · Cited by 43 · cited 2×
“Characteristics of Responders and Nonresponders Four trials suggested that younger patients with less impairment, who are less focused on symptoms, adherent to cognitive therapy programs, and avoid over- and underexertion (that is, they stay within their energy envelope) are more likely to improve in some measures of…”
BackgroundGoudsmit, E. M., Ho-Yen, D. O., & Dancey, C. P. (2009) · Patient Education and Counseling · doi:10.1016/j.pec.2009.05.015 · Cited by 37 · cited 3×
“In some trials, counseling and behavior therapies improved fatigue (8, 38, 39, 41, 43, 46, 48, 62), physical function (Figure 1) (38, 40, 41, 43, 44, 48), quality of life (42, 45), work impairment (38, 48), and the clinical global impression of change scale (38, 48, 59) (low to moderate strength of evidence).”
BackgroundDavenport, T. E., Stevens, S. R., VanNess, J. M., Snell, C. R., & Phelan, T. L. L. (2010) · Physical Therapy · doi:10.2522/ptj.20090047 · Cited by 36
Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Smith, M. E. B., Nelson, H. D., Haney, E. M., Pappas, M., Daeges, M., Wasson, N., & McDonagh, M. S. (2014) · doi:10.23970/ahrqepcerta219 · Cited by 33
Williams, G. D., Waterhouse, J. M., Mugarza, J. A., Minors, D. S., & Hayden, K. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01058.x · Cited by 29 · cited 3×
“One trial met criteria for good quality (31, 33), 5 for fair quality (29, 32, 34, 35), and 1 for poor quality (30).”
BackgroundDíaz‐Mitoma, F., Turgonyi, E., Kumar, A., Lim, W., Larocque, L., & Hyde, B. M. (2003) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v11n02_06 · Cited by 29 · cited 4×
“Some trials were primarily intended to measure intermediate outcomes, such as natural killer cell–mediated cytotoxicity (25), and most were underpowered for the health outcomes relevant to this systematic review.”
BackgroundInfluentialProvision of social support to individuals with chronic fatigue syndrome
Jason, L. A., Roesner, N., Porter, N. S., Parenti, B., Mortensen, J., & Hoyt, L. T. (2009) · Journal of Clinical Psychology · doi:10.1002/jclp.20648 · Cited by 28 · cited 5×
“Five trials met criteria for good quality (44–48), 6 for fair quality (36–38, 40, 41, 43), and 3 for poor quality (8, 39, 42).”
BackgroundInfluentialDepressive symptoms and pragmatic rehabilitation for chronic fatigue syndrome
Wearden, A. J., Dunn, G., Dowrick, C. F., & Morriss, R. K. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107474 · Cited by 26 · cited 3×
“Characteristics of Responders and Nonresponders Four trials suggested that younger patients with less impairment, who are less focused on symptoms, adherent to cognitive therapy programs, and avoid over- and underexertion (that is, they stay within their energy envelope) are more likely to improve in some measures of…”
BackgroundDietary intervention in chronic fatigue syndrome
Hobday, R. A., Thomas, S., O’Donovan, A., Murphy, M., & Pinching, A. J. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00857.x · Cited by 25 · cited 3×
“One trial met criteria for good quality (31, 33), 5 for fair quality (29, 32, 34, 35), and 1 for poor quality (30).”
BackgroundHlavaty, L. E., Brown, M. M., & Jason, L. A. (2011) · Rehabilitation Psychology · doi:10.1037/a0024118 · Cited by 24 · cited 1×
“Characteristics of Responders and Nonresponders Four trials suggested that younger patients with less impairment, who are less focused on symptoms, adherent to cognitive therapy programs, and avoid over- and underexertion (that is, they stay within their energy envelope) are more likely to improve in some measures of…”
BackgroundMeirleir, K. L. D., Bateman, L., Darragh, A., & Carruthers, B. M. (2012) · Cited by 23
The Effect of Acclydine in Chronic Fatigue Syndrome: A Randomized Controlled Trial
The, G. K. H., Bleijenberg, G., & van der Meer, J. W. M. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020019 · Cited by 22 · cited 3×
“One trial met criteria for good quality (31, 33), 5 for fair quality (29, 32, 34, 35), and 1 for poor quality (30).”
BackgroundModerators of the treatment response to guided self-instruction for chronic fatigue syndrome
Tummers, M., Knoop, H., van Dam, A., & Bleijenberg, G. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.01.007 · Cited by 22
Sutcliffe, K., Gray, J., Tan, M. P., Pairman, J., Wilton, K., Parry, S. W., & Newton, J. L. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02225.x · Cited by 19 · cited 4×
“These included GET involving an exercise plan with structured incremental increases in exercise over time (23, 48, 50, 52, 53), qigong exercise (49, 51), and home orthostatic training (54).”
BackgroundMethodInfluentialRedefining the Chronic Fatigue Syndrome
Ganiats, T. G. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0357 · Cited by 17 · cited 1×
“The Institute of Medicine recently released new diagnostic criteria for CFS that require the presence of postexertional malaise, unrefreshing sleep, and either cognitive impairment or orthostatic intolerance (7, 72).”
Wearden, A. J., Riste, L., Dowrick, C. F., Chew-Graham, C. A., Bentall, R. P., Morriss, R. K., Peters, S., Dunn, G., Richardson, G. A., Lovell, K., et al. (2010) · Research Explorer (The University of Manchester) · Cited by 13
Effect of Galantamine Hydrobromide in Chronic Fatigue Syndrome
Blacker, C. V. R., Greenwood, D. T., Wesnes, K. A., Wilson, R. J., Woodward, C., Howe, I., & Ali, T. (2004) · JAMA · doi:10.1001/jama.292.10.1195 · cited 4×
“Galantamine was associated with higher rates of withdrawal and attrition than was placebo, demonstrating a dose-dependent relationship; the highest rates were seen at doses of 15 mg or more per day (26).”
BackgroundInfluential
Research works printed but not linked: 5
- Jason LA, 2013, Fatigue, 1, 168
- Öckerman PA, 2000, Clin Pract Alternat Med, 1, 88
- Chambers D, 2006, J R Soc Med, 99, 506
- Edmonds M, 2004, Cochrane Database Syst Rev, CD003200
- 10.7326/M15-03577 · DOI
Cited by
Sorted by citations
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127
“Abnormal fatigue could correspond to form of chronic fatigue syndrome, in this setting one possible remedy is exercise therapy [30].”
BackgroundLim, E., Ahn, Y., Jang, E.-S., Lee, S., Lee, S., & Son, C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02269-0 · Cited by 489
“These studies may be promising; however, no therapeutics that can cure CFS/ME or objective diagnostic methods are available yet [13].”
BackgroundMyalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Rivera, M. C., Mastronardi, C. A., Silva, C., Arcos‐Burgos, M., & Lidbury, B. A. (2019) · Diagnostics · doi:10.3390/diagnostics9030091 · Cited by 329
“Complementary and alternative medicine Nutritional supplements, Acetyl-l-carnitine, Essential fatty acids, Magnesium, Vitamins, Coenzyme Q10 plus Nutritional supplements may improve ME/CFS-related physical and mental fatigue in patients with specific nutritional deficiencies [215].”
BackgroundTLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Luchner, M., Reinke, S., & Milicic, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020142 · Cited by 296
“In patients with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), treatment with the poly-IC12U drug rintatolimod led to an improvement in exercise tolerance and showed dose-sparing effects in a Phase III clinical trial in 2012 [23].”
BackgroundInfluentialKomaroff, A. L., & Lipkin, W. I. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.002 · Cited by 276
“Moreover, controlled studies of the antidepressant fluoxetine in people with ME/CFS have demonstrated no benefit [32].”
Metadata
- Authors
- Smith, M. E. B., Haney, E., McDonagh, M., Pappas, M., Daeges, M., Wasson, N., Fu, R., & Nelson, H. D.
- Affiliations
- Oregon Health & Science University (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-06-16
- Volume
- 162
- Issue
- 12
- Pages
- 841-850
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1601664045
- Cited by
- 142
- References
- 68
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 9 · 2023: 7 · 2022: 12 · 2021: 18 · 2020: 10 · 2019: 14 · 2018: 10 · 2017: 18 · 2016: 17 · 2015: 12
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (290201200014I)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- chronic fatigue syndrome, treatment effectiveness, treatment harms, immunomodulators, graded exercise therapy, counseling, complementary therapy, galantamine, cortisol, isoprinosine, valganciclovir, fluoxetine, fatigue, quality of life, case definition
- MeSH terms
- Adult, Complementary Therapies, Antiviral Agents, Counseling, Encephalomyelitis, Exercise Therapy, Humans, Immunologic Factors, Poly I-C, Poly U, Quality of Life, Fatigue Syndrome, Chronic, Cognitive Behavioral Therapy, Myalgia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review